HSBC Knock-Out PGR/ DE000HS9WKL1 /
11/10/2024 17:43:13 | Chg.0.000 | Bid11/10/2024 | Ask11/10/2024 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.680EUR | 0.00% | 0.680 Bid Size: 200,000 |
0.690 Ask Size: 200,000 |
Progressive Corporat... | 179.4661 USD | 31/12/2078 | Call |
GlobeNewswire
02/09
Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to ...
GlobeNewswire
30/08
MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Paten...
GlobeNewswire
30/08
Emergent BioSolutions’ ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA App...
GlobeNewswire
29/08
The Alignment Studio Announces Launch of Women’s Health Physiotherapy Services in Melbourne
GlobeNewswire
28/08
AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodege...
GlobeNewswire
26/08
Avalyn Announces Upcoming Presentations on its Lead Program AP01, Inhaled Pirfenidone, for the Treat...
GlobeNewswire
22/08
Abata Therapeutics Receives FDA Fast Track Designation for ABA-101 for the Treatment of Progressive ...
GlobeNewswire
21/08
CPAClub™ and Caseware™ Partner to Elevate Audit Quality for Progressive Accounting Firms
GlobeNewswire
19/08
Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa
GlobeNewswire
19/08
Fulcrum Therapeutics Strengthens Leadership Team with the Appointments of Isabel Kalofonos as Chief ...
GlobeNewswire
15/08
Abata Therapeutics Announces Strategic Investment from Bristol Myers Squibb Supporting Advancement o...
GlobeNewswire
14/08
Atsena Therapeutics Receives Rare Pediatric Disease Designation from the U.S. FDA for ATSN-201 Gene ...
GlobeNewswire
14/08
Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule
GlobeNewswire
13/08
Eyenovia to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
GlobeNewswire
12/08
Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate Update